Regulatory T Cells Reversibly Suppress Cytotoxic T Cell Function Independent of Effector Differentiation  by Mempel, Thorsten R. et al.
Immunity 25, 129–141, July 2006 ª2006 Elsevier Inc. DOI 10.1016/j.immuni.2006.04.015Regulatory T Cells Reversibly Suppress
Cytotoxic T Cell Function
Independent of Effector DifferentiationThorsten R. Mempel,1,4 Mikael J. Pittet,2,3,4,*
Khashayarsha Khazaie,2,3 Wolfgang Weninger,1
Ralph Weissleder,2 Harald von Boehmer,3
and Ulrich H. von Andrian1





2Center for Molecular Imaging Research
Massachusetts General Hospital









Mechanisms of dominant tolerance have evolved
within themammalian immune system to prevent inap-
propriate immune responses. CD4+CD25+ regulatory T
(Treg) cells have emerged as central constituents of
this suppressive activity. By using multiphoton intra-
vital microscopy in lymph nodes (LNs) of anesthetized
mice, we have analyzed how cytotoxic T lymphocytes
(CTLs) interact with antigen-presenting target cells in
the presence or absence of activated Treg cells. Non-
regulated CTLs killed their targets at a 6.6-fold faster
rate than regulated CTLs. In spite of this compromised
effector activity, regulated CTLs exhibited no defect in
proliferation, induction of cytotoxic effector mole-
cules and secretory granules, in situ motility, or ability
to form antigen-dependent conjugates with target
cells. Only granule exocytosis by CTLs was markedly
impaired in the presence of Treg cells. This selective
form of regulation did not require prolonged contact
between CTLs and Treg cells but depended on CTL re-
sponsiveness to transforming growth factor-b. CTLs
quickly regained full killing capacity in LNs upon se-
lective removal of Treg cells. Thus, Treg cells reversibly
suppress CTL-mediated immunity by allowing acqui-
sition of full effector potential but withholding the
license to kill.
Introduction
It has been known for more than a decade that
CD4+CD25+ Treg cells prevent autoimmune responses
by self-reactive conventional T cells (Sakaguchi et al.,
1995), but the mechanisms of Treg-mediated immuno-
suppression are still poorly understood. Tissue-culture
experiments have shown that Treg cells can inhibit the
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4 These authors contributed equally to this work.activation-induced proliferation of effector T cells in
a manner requiring direct cell-cell contact (Shevach,
2002). However, recent in vivo studies indicate that inhi-
bition of effector T cell proliferation is not always neces-
sary to achieve Treg-dependent peripheral tolerance
(Klein et al., 2003a; Lin et al., 2002). For example, in a
tissue-transplant model, Treg cells inhibited allograft
rejection but not the proliferation of alloreactive CD8+
effector T cells (Lin et al., 2002). Similarly, antigen
(Ag)-specific Treg cells and CD8
+ T cells proliferated
massively side-by-side in Ag-draining lymph nodes
(LNs) (Chen et al., 2005a). Despite the failure of Treg cells
to limit cytotoxic T lymphocyte (CTL) proliferation in this
setting, tumors expressing the cognate model Ag hem-
agglutinin (HA) did not undergo CTL-mediated tumor
rejection, whereas tumors were effectively eliminated
when CTLs were activated in the absence of HA-specific
Treg cells (Chen et al., 2005a). The activated Treg cells
exerted this suppressive activity by preventing CD8+ T
cells from becoming cytotoxic in the draining LN (Chen
et al., 2005a). Although the reasons for this Treg cell-
induced impairment of cytotoxicity have not been deter-
mined, a number of mechanisms are conceivable,
including defects in CTLs due to: altered migratory
properties; inability to recognize or to form conjugates
with Ag-bearing target cells; lack of cytotoxic effector
molecules; failure to assemble or exocytose lytic gran-
ules; or any combination thereof.
Here we have systematically explored each of these
candidate suppressor mechanisms by directly visualiz-
ing the interactions of CTLs and Ag-presenting target
cells as well as Treg cells in situ. To this end, an estab-
lished model to study CTL responses against a subcuta-
neously injected HA-expressing tumor cell line (Chen
et al., 2005a) was adapted to perform multiphoton intra-
vital microscopy (MP-IVM) in Ag-draining LNs of anes-
thetized mice (Mempel et al., 2004). We found that
primed CTLs migrate normally and respond to encoun-
ter of Ag-presenting target cells in LNs by forming stable
conjugates in the absence or presence of Treg cells.
However, the ability of regulated CTLs to induce target
cell lysis was greatly impaired. Ex vivo analysis of
CTLs showed that failure to kill target cells in vivo was
correlated with impaired release of lytic granules, while
cellular granule content and endowment with lytic effec-
tor molecules was unchanged. Suppression depended
on transforming growth factor-b (TGF-b) signaling in
CTLs and was reversible upon in vivo removal of Treg
cells after CTL priming, but did not require prolonged
physical interactions of CTLs with Treg cells. These ob-
servations indicate that Treg cells can reversibly blunt
T cell responses by selectively modulating a terminal
effector function of primed CD8+ T cells.
Results
Imaging Apoptosis of Target B Cells In Vivo
To induce CTL differentiation in situ, a small number (13
105) of naive transgenic CD8+ T cells expressing en-
hanced green fluorescent protein (EGFP) and a T cell
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130Figure 1. CTL-Mediated Killing of Ag-Pulsed B Cells Can Be Monitored through Changes in Motility and the R/B Fluorescence Intensity Ratio
(A) Experimental protocol. BALB/c mice received intravenous injections of HA-specific EGFP+ transgenic CD8+ T cells, followed by implantation
of HA-expressing tumors into the right footpad. 5–7 days later, B cells were fluorescently labeled with CMTMR and Hoechst33342. Labeled
antigen-pulsed or unpulsed B cells were injected i.v. and CTL activity was monitored in the tumor-draining LN.
(B) MP-IVM micrographs of tumor-draining LNs 4 hr after injection of unpulsed (left) or Ag-pulsed (right) B cells. Arrows identify killed B cells, i.e.,
immotile cells with reduced red-to-blue fluorescence ratios (scale bar equals 20 mm). Bottom panels show merged and single-color fluorescent
images of representative live (left) and killed (right) B cells (scale bar equals 5 mm).
(C) Ag-pulsed B cells labeled with CMTMR (CellTracker Orange) were harvested from tumor-draining CTL-containing LNs 6 hr after injection,
stained with Annexin V, and analyzed by flow cytometry.
(D) Unpulsed (left) and Ag-pulsed (right) B cells in tumor-draining LNs were analyzed for R/B intensity ratios and mean track velocities at 2 hr
(empty symbols) and 5 hr (filled symbols) after i.v. injection. Medians are shown in red and are not statistically different in absence of Ag (R/B
ratio of 1.54 versus 1.64, p = 0.18, and velocity of 7.47 versus 6.46 mm/min, p = 0.30, for 2 and 5 hr) but differ in presence of Ag (R/B ratio of
1.47 versus 0.78, p = 0.0021, and velocity of 8.50 versus 3.83 mm/min, p = 0.0001, for 2 and 5 hr). Thresholds separating viable from dead cells
(dashed lines) were defined as described in Experimental Procedures.
(E) Unpulsed (left) and Ag-pulsed B cells (right) were analyzed in tumor-draining LNs for R/B ratios from 90 to 360 min after i.v. injection. Each data
point represents an individual B cell; data were pooled from 7 (2Ag) or 8 (+Ag) recordings in three independent experiments per group.receptor (TCR) recognizing an epitope from influenza
virus-derived HA in H-2Kd (Morgan et al., 1996) were
adoptively transferred to BALB/c recipients (Figure 1A).
It has been shown previously that subsequent footpad
implantation of HA-transduced CT44 colon carcinoma
cells (Klein et al., 2003b) as a continuous source of Ag in-
duces massive expansion of HA-specific donor T cells in
the draining popliteal LN (popLN). The activated cellseventually give rise to highly cytotoxic effectors, leading
to macroscopic tumor shrinkage from day 7 onward. HA
peptide-pulsed splenocytes obtained from BALB/c
mice and adoptively transferred on day 6 after tumor
implantation are rapidly eliminated in tumor-draining
popliteal LN (popLN), indicating that full-fledged CTLs
specific for the tumor-expressed HA arise in this LN prior
to their peripheralization (Chen et al., 2005a).
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nodal CTL function: on day 5 after tumor implantation,
purified B cells were adoptively transferred after differ-
ential fluorescent labeling of DNA and cellular proteins
with Hoechst33342 (blue) and CMTMR (red), respec-
tively. This staining protocol was based on the expecta-
tion that lysed cells would lose soluble cytoplasmic (red)
proteins, whereas the Hoechst33342 emission would in-
crease as nuclei become apoptotic (Kohler et al., 2003).
The double-stained B cells homed avidly to popLNs and
mingled in the superficial paracortex with EGFP-
expressing CTLs (see Movies S1 and S2 in the Supple-
mental Data available with this article online). Whereas
Ag-free control B cells retained their blue and red fluo-
rescence and were highly motile, an increasing fraction
of HA-peptide-pulsed B cells became immotile and un-
derwent a dramatic change in appearance; they became
visibly smaller and lost most of their red fluorescence
while gaining in blue intensity (Figure 1B and Figure S1).
Many immotile B cells also emitted detectable green
fluorescence, presumably due to spectral overlap of
the more intense Hoechst33342 emission at wave-
lengths detected through the green channel (525/50
nm), which was not observed with motile B cells. Thus,
when red, green, and blue channels were merged, the
motile control B cells had a reddish-purple color while
most immotile Ag-pulsed B cells appeared bluish-white.
Flow cytometric analysis of Ag-pulsed donor B cells in
single-cell suspensions of CTL-containing recipient
popLNs revealed that the loss of red fluorescence was
invariably associated with cell death (Figure 1C). When
B cell fate was monitored over the first 6 hr after adop-
tive transfer, control B cells always exhibited high motil-
ity and a constant red-to-blue fluorescence intensity ra-
tio (henceforth called R/B ratio; see Experimental
Procedures), whereas the Ag-pulsed target cells gave
rise to a progressively larger stationary population of
nonviable cells with low R/B ratios (Figures 1D and 1E).
Kinetics of CTL-Target Cell Encounters In Vivo
Having determined that motility in conjunction with the
R/B ratio are empirical indicators of B cell viability in
situ, we performed MP-IVM to investigate how EGFP+
CTLs interact with their targets. The CTLs rapidly formed
stable conjugates with viable Ag-pulsed B cells
(Figure 2A), but they made only transient contacts with
unpulsed B cells (Figures 2A and 2C and Movie S2). Cu-
riously, CTLs appeared to be able to discern live from
dead victims; more than 95% of newly formed stable
contacts with Ag-pulsed targets involved live B cells,
whereas CTLs ignored dead B cells even when they
had been killed only minutes earlier. Conjugate forma-
tion with live targets was typically followed by a period
during which monogamous CTL-B cell pairs migrated
together, with B cells always leading the way (Movie
S3), similar to what has been described for antigen-stim-
ulated B cells receiving help from CD4+ T cells (Okada
et al., 2005). Because it is not possible to measure the in-
tercellular forces during these encounters, we can not
determine whether CTLs were pushing the B cells or
whether the B cells were dragging the CTLs. It should
be noted, however, that the microtubule-organizing
center (MTOC) in interacting T cells has been shown to
polarize toward the contact site during a stable contactwith an APC (Dustin et al., 1997; Stinchcombe et al.,
2001b). One might speculate that this polarization may
preclude simultaneous migration on a substrate other
than the APC to which the CTL is attached, since in mi-
grating lymphocytes, the MTOC is typically located at
the trailing end of the cell relative to the nucleus. The
initial high motility phase of CTL-B cell conjugates was
followed after w10 min by sometimes gradual and
sometimes abrupt slowing of the conjugates ending in
complete immotility. Conjugate arrest was seen in
71% of all interactions that could be observed from be-
ginning to end; in a minority of conjugates (29%), the
CTLs disengaged from apparently intact B cells
(Figure 2B). B cell arrest was invariably followed within
w10 min by a sudden drop in R/B ratio, which was occa-
sionally preceded, but in most cases followed by, de-
tachment of the CTL (Figures 2A and 2C–2E). In several
instances, we recorded sudden protrusions of red fluo-
rescent material from B cells undergoing cytolysis rem-
iniscent of membrane blebbing, which has been ob-
served when cells are killed in vitro (Stinchcombe
et al., 2001b). Because of the high B cell motility, limited
size of the observed lymph node volume, and limited du-
ration of recordings (60 min), a few intact B cells that dis-
engaged from CTLs (n = 9) might have died after they mi-
grated out of the field of observation or after the
recording ended. If this was the case, one would have
expected to observe also B cells that migrate into the
field of view and, without observed contact to a CTL, ar-
rest and lose structural integrity. We have recorded
three such events during 8 hr of continuous observation
and, therefore, cannot exclude the possibility that a frac-
tion (w1/3) of B cells that remain intact after CTL disso-
ciation might eventually die unobserved.
The average time interval between contact initiation
and overt signs of structural target cell damage (17 6
7 min, ranging from 9 to 25 min) in this in vivo setting
was longer than what has been reported for CTL lysis
in vitro (Stinchcombe et al., 2001b). However, it is likely
that irreversible cytotoxic damage was incurred already
when target B cells underwent migratory arrest. More-
over, the CTLs were remarkably efficient; within 6 hr
after antigen-pulsed B cell injection, very few viable
target cells were left in CTL-containing LNs. Instead,
MP-IVM recordings at late time points after B cell trans-
fer revealed a conspicuous population of condensed,
irregularly shaped aggregates of red and blue fluores-
cent material, which became more frequent over time
and were not seen when control B cells were infused.
These objects probably represented phagolysosomes
of macrophages or dendritic cells that had ingested
fluorescent material from lysed target cells (Movie S4).
Treg Cells Impair CTL Lytic Function, but Not
Conjugate Formation with Target Cells
Having established an MP-IVM approach to visualize
and analyze the kinetics and efficacy of CTL-mediated
target cell killing, we asked how the presence of acti-
vated Treg cells affects CTL function. Coadoptive trans-
fer of HA-specific Treg cells with HA-specific CD8
+ T cells
followed by implantation of CT44 tumors results in
clonal expansion of both T cell populations, but the en-
suing CTLs fail to reject the tumors (Chen et al., 2005a).
Accordingly, regulated CTLs that developed in popLNs
Immunity
132Figure 2. Sequential Steps during Killing of Ag-Pulsed B Cells by CTLs
(A) Ag-free B cells (red/purple) are scanned by a CTL (green) in a series of short-lasting contacts (left). The time interval from the beginning of each
recording is shown as minutes and seconds. Upon encounter with an Ag-pulsed B cell (right), a CTL forms a stable, motile conjugate with its
target. At 13 min, the conjugate becomes permanently arrested, but B cell color is still unchanged (inset). A color change in the B cell indicative
of loss of structural integrity is first apparent afterw20 min and remains visible until the end of the recording at 33:30 min, at which time the lysed
cell has extruded a prominent membrane bleb (inset). Yellow dots track the position of the CTL’s centroid at 15 s time intervals (scale bar equals
20 mm). The still images of CTL-B cell interactions without and with Ag are from Movies S2 and S3, respectively.
(B) Outcome of 80 individual CTL-B cell interactions from four independent experiments. ‘‘Lysis’’ defines B cells with a R/B ratio that dropped
below 0.95 after CTL interaction (see Experimental Procedures), ‘‘detachment’’ defines B cells that detached from CTLs and retained an R/B ratio
above 0.95, and ‘‘undetermined outcome’’ defines CTL-B cell conjugates that left the recorded region before lysis or detachment could be ob-
served.
(C) Single-cell recordings of time-averaged migratory velocity (green line) and R/B ratio (red line) as parameters of viability of B cells during en-
counters with CTLs (gray bars). Transient encounters of unpulsed B cells with CTLs did not alter either parameter, whereas Ag-pulsed B cells first
became immotile and, subsequently, their R/B ratio dropped below the viability threshold (dashed line).
(D) Mean duration of the different phases of B cell interactions with CTLs. Light gray arrows reflect motile interactions until either detachment or
motility arrest; dark gray arrows show time from motility arrest to structural lysis; black arrow reflects time from structural lysis to detachment of
the CTLs. Numbers on the right show the mean duration (6 SD) of each phase in minutes.
(E) Data from (D) plotted as cumulative frequency histogram.
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133in the presence of HA-specific Treg cells failed to kill
Ag-pulsed B cells (Figure 3A). However, B cells interact-
ing with regulated CTLs became much less frequently
immotile. Instead, the B cell-CTL couples continued to
migrate vigorously. Eventually, most interactions were
terminated by detachment of the regulated CTLs or,
owing to the long duration and dynamic nature of the
interactions, the migrating conjugates left the imaged
tissue volume (Figures 3B–3D and Movie S5). Both reg-
ulated and nonregulated CTLs had the same gross dis-
tribution within popLNs, displayed equivalent migratory
activity (Figure S2 and Movie S5), polarized similarly
toward target B cells during the motile interaction phase
(Figure S2), and efficiently formed stable conjugates
with their targets (95.8% and 94.7% interactions with
Ag-pulsed B cells and regulated or unregulated CTLs,
respectively, lasted for >3 min; in comparison, the upper
95% Cl of mean for interactions with control unpulsed
targets was 2.7 min, data not shown and Figure 3E).
In comparison to nonregulated CTL-B cell conjugates,
Ag-pulsed B cell conjugates with regulated CTLs that
could be followed from beginning to end (26% of all con-
jugates observed) lasted twice as long before either de-
taching (17%) or, less frequently, resulting in B cell death
(Figure 3E). In the few cases in which regulated CTLs
induced B cell arrest (9%), the time required for sub-
sequent loss of the target’s structural integrity and even-
tual detachment of the CTLs was the same as with
nonregulated CTLs, suggesting that these late steps in
the killing process were not influenced by Treg cells
(Figure 3E). However, because regulated CTL-B cell
conjugates persisted longer and resulted less frequently
in a ‘‘lethal hit,’’ there was a 6.6-fold difference in the fre-
quency of killing events during the total observed time of
motile CTL-B cell conjugation; the hourly kill rate was
2.42/hr and 0.36/hr in the absence and presence of
Treg cells, respectively (Figure 3F). Thus, Treg cell-medi-
ated CTL suppression in LNs does not interfere with
CD8+ T cell expansion, distribution, or motility, nor
does it affect the CTL’s ability to detect agonist TCR
ligands on B cells or to form antigen-specific stable con-
jugates. Suppression in this setting appears to manifest
itself exclusively in compromised lytic activity.
Regulated CTLs Are Sufficient in Content but Not
Release of Lytic Granules
When CD8+ T cells differentiate into CTLs, they assem-
ble specialized secretory granules that store cytotoxic
effector molecules. Cytolysis requires the translocation
and exocytosis of these lytic granules at the CTL-target
cell interface, where the granule contents are endocy-
tosed by the target and then trigger several proapop-
totic pathways (Lieberman, 2003; Trapani and Smyth,
2002). Despite the dramatic difference in cytotoxic po-
tential, the size, number, and subcellular distribution of
lytic granules in regulated and nonregulated CTLs was
virtually identical (Figures 4A and 4B). Likewise, we
found no difference between regulated and nonregu-
lated CTLs in mRNA expression of multiple effector mol-
ecules (Figure 4C) or the transcription factors T-bet and
eomesodermin, which are required for optimal CTL dif-
ferentiation (Pearce et al., 2003; Sullivan et al., 2003)
(data not shown). The expression of lytic effector mole-
cules may also be regulated posttranscriptionally. Wecould not assess perforin content in CTLs due to lack
of an adequate mAb and/or staining protocol for specific
staining, yet we found no significant difference between
regulated and nonregulated CTLs in granzyme B con-
tent (Figure S6). However, the diminished cytolytic activ-
ity of regulated CTLs correlated with a marked delay and
decreased frequency in activation-induced degranula-
tion, as determined by mobilization of the lysosomal
marker CD107a to the cell surface upon encounter
with Ag-presenting cells (Figure 5A and Figure S3). De-
granulation of regulated CTLs was strongly impaired
(between 75% and 95% decrease) during the first 30
min after Ag challenge. This early impairment of degran-
ulation may be particularly important because our in vivo
observations indicate that CTLs have a constrained win-
dow of opportunity to induce target cell death before
conjugates dissociate (>95% motile interactions last
for less than 30 min, mean 6 SD, 8.4 6 7.2 min). Thus,
impaired granule exocytosis is a plausible mechanism
for the failure of regulated CTLs to eliminate target cells
to the extent observed in vivo.
CTL Suppression Depends on TGF-b Signaling
How might Treg cells modulate the effector function of
intranodal CTLs? In many settings, undesired self-
targeted immune responses are suppressed by TGF-b
(Gorelik and Flavell, 2002). Recent work indicates that
Treg cells are relatively poor producers of this cytokine,
but they have been suggested to function in a TGF-b-
dependent fashion by inducing TGF-b production by
other cells (Kullberg et al., 2005). Indeed, TGF-b also
plays a role in the present model; HA-specific CTLs
that expressed a dominant-negative TGF-b type II re-
ceptor (dnTGFbRII) (Gorelik and Flavell, 2000) displayed
similar kinetics of expansion as wild-type CTLs and
displayed comparable cytotoxic activity, but they effi-
ciently eliminated HA-expressing tumors even when
Treg cells were present. Thus, although there are other
mechanisms by which Treg cells can exert immunosup-
pressive activities (Shevach, 2002), responsiveness to
TGF-b is prerequisite to CTL suppressibility in this
model (Chen et al., 2005a). Indeed, when HA-specific
dnTGFbRII CTLs were harvested from popLNs on day
6 or 7 after tumor implantation, they degranulated
rapidly upon restimulation regardless of whether they
were generated in the presence or absence of Treg cells,
indicating that compromised cytotoxicity and impaired
degranulation depend on TGF-b (Figure 5B). In contrast,
the mere addition of TGF-b to cultures of nonregulated
CTLs was not sufficient to block degranulation acutely
(data not shown). Thus, other suppressive signals gen-
erated by Treg cells and/or other cells may be needed
for CTL regulation.
Suppression of CTLs Is Reversed upon Removal
of Treg Cells
Next, we asked whether Treg cell-mediated suppression
of CTLs is reversible. Congenic Thy1.2+ CTLs and
Thy1.1+ Treg cells were allowed to proliferate in CT44
tumor-bearing Thy1.2+ hosts. On days 5 and 6, at
a time when virtually all HA-specific CD8+ T cells had
been activated and induced to proliferate in popLNs,
the Treg cells were selectively depleted by anti-Thy1.1
mAb injection (Figure 6A). 2 days after Treg cell depletion,
Immunity
134Figure 3. CTL-Mediated Induction of Motility Arrest and Lysis of B Cells Is Compromised in the Presence of Treg Cells
(A) R/B ratios of Ag-pulsed B cells imaged between 90 and 360 min after i.v. injection into mice containing regulated CTLs. Data are pooled from
11 recordings in 4 independent experiments.
(B) Representative micrographs showing a regulated CTL interacting with Ag-presenting B cells. After forming a motile conjugate with a B cell
marked ‘‘1’’ for 25 min, the CTL engages with a second B cell (‘‘2’’) and subsequently detaches from the first B cell, without inducing motility arrest
or color change in either target cell. Scale bar equals 20 mm.
(C) Single-cell recording of time-averaged instantaneous migratory velocity (green line) and R/B ratio (red line) as indicators of viability of a B cell
during an encounter with a regulated CTL (gray bar).
(D) Outcome of 122 distinct CTL-B cell interactions from four independent experiments. ‘‘Lysis’’ defines B cells with a R/B ratio that dropped
below 0.95 after CTL interaction (see Experimental Procedures), ‘‘detachment’’ defines B cells that detached from CTLs and retained an R/B ratio
above 0.95, and ‘‘undetermined outcome’’ defines CTL-B cell conjugates that left the recorded region before lysis or detachment could be
observed.
(E) Cumulative frequencies of CTL-B cell conjugate persistence during each phase defined in Figure 2D. Top: persistence of motile conjugates
from the moment of engagement to either motility arrest or early detachment. Results for interactions between CTLs and unpulsed B cells are
shown in gray. Results with Ag-pulsed B cells are plotted for conjugates formed in the absence (black) or presence (red) of Treg cells. Middle:
persistence of intact B cells (R/B ratio > 0.95) after motility arrest. Bottom: conjugate persistence from lysis to CTL detachment. All interactions
for which the beginning and end of the interactive phase was observed were included. Motile interaction time was significantly increased in the
presence of Treg cells (p < 0.0001), but times from arrest to lysis and from lysis to detachment were not significantly different.
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135Figure 4. Treg Cells Do Not Compromise Effector Differentiation
(A) Fluorescent micrographs of nonregulated (left) and regulated CTL (right) purified from tumor-draining LNs at day 6 of the immune response.
Cells were stained ex vivo for lytic granules (Lysotracker Red [Lyubchenko et al., 2001; Stinchcombe et al., 2001b]), nuclear DNA (Hoechst33342,
blue), and cellular protein (CFSE, green) and imaged by confocal microscopy (scale bar equals 5 mm). Results are representative of three exper-
iments.
(B) LN-derived regulated and nonregulated CTLs and naive CD8+ T cells were assayed for lytic granule content by flow cytometry. Results are
representative of two experiments with three mice per group. Mean and standard deviation are shown.
(C) Relative mRNA content (normalized to CD33) for various effector molecules in FACS-purified CTLs (1000 cells/sample). Nonregulated (black
bars) and regulated (white bars) CTLs were isolated from day 7 tumor-draining LNs and analyzed by real-time PCR after reverse transcription.
Results are representative of two independent experiments with three mice per group, each sample analyzed in triplicate. Mean and standard
deviation are shown. Pfn, Perforin; GrA, GrB, Granzyme A, B; IFN-g, Interferon-g; FasL, Fas ligand.the CTLs in tumor-draining LNs were highly cytotoxic,
and the magnitude of their apparent desuppression cor-
related with the degree of Treg cell depletion (Figure 6B
and Figure S4; data not shown). Thus, sustained CTL
suppression requires the continuous presence of Treg
cells.
CTL Suppression Does Not Require Prolonged
Physical Contacts with Treg Cells
Having determined that the continued physical pres-
ence of Treg cells in LNs after priming is required for
CTL suppression, we set out to visualize how Ag-spe-
cific Treg cells behave and interact with CTLs in tumor-
draining LNs. We adoptively transferred T cells from do-
nor mice in which HA-specific CD8+ T cells and Treg cells
expressed red (DsRed) and green (EGFP) fluorescent
tags, respectively. MP-IVM recordings during days 6
and 7 after tumor implantation showed that Treg cells
as well as CTLs were highly motile and occupied primar-
ily the deep paracortex and cortical ridge of tumor-drain-
ing LNs (Figures S2 and S5). Occasional CTLs and Treg
cells could also be observed in B cell follicles. Unregu-
lated CTL-B cell interactions were seen primarily in the
T cell area where B cells enter LNs via high endothelial
venules and are quickly eliminated by the resident
CTLs. In the presence of Treg cells, CTL-B cell contacts
were still initiated in the T cell zone, but some conjugates
could be observed to enter follicles. In several instances,
Treg cells and CTLs were recorded while undergoing
cytokinesis, and a subset of cells (mostly CTLs) occa-sionally formed small clusters, presumably around en-
dogenous Ag-presenting cells (Movies S4 and S6). How-
ever, nearly all physical encounters of Treg cells with
CTLs lasted only a few minutes; tight conjugates of
Treg cells and CTLs were rarely observed (Figures 7A
and 7B and Movie S7), which is in line with another study
that failed to detect prolonged Treg cell-CD4
+ T cell inter-
actions during the priming phase in a model of autoim-
mune diabetes (Tang et al., 2006). In the few instances
when Treg cells and CTLs showed prolonged colocaliza-
tion, we did not detect a stable contact zone between
them. Rather, they seemed to congregate around other
nonfluorescent structures, possibly Ag-presenting cells.
Discussion
Treg cells can inhibit immune responses in a variety of
settings, but the mechanisms of suppression are still
largely unclear. Here, we have described an imaging-
based approach to examine the cellular functions that
are altered in CTLs in the presence of activated Treg
cells. We made use of a model in which regulated
CTLs in tumor-draining LNs undergo normal clonal
expansion but fail to exert cytotoxicity or to reject Ag-
presenting tumors (Chen et al., 2005a). Unexpectedly,
we found that regulated CTLs underwent essentially
normal effector differentiation. Compared to nonregu-
lated CTLs, the only detectable defect in regulated
CTLs was a marked attenuation of Ag-triggered lytic
granule release.(F) The hourly killing rate of B cells by regulated and nonregulated CTLs was calculated as the ratio of the total number of observed killing events
(defined by irreversible motility arrest) over the total cumulative duration of all recorded motile CTL-B cell conjugates from 3 to 6 experiments per
group (that isw100 min for CTL-HA– B cell conjugates, andw700 min orw2000 min for CTL-HA+ B cell conjugates in the absence or presence of
Treg cells, respectively).
Immunity
136Figure 5. Treg Cells Selectively Interfere with
CTL Granule Exocytosis in a TGF-b-Depen-
dent Manner
(A) CTL degranulation as determined by cell-
surface mobilization of the lysosomal marker
CD107a (Betts et al., 2003) was measured by
flow cytometry in CTL from tumor-draining
LNs of mice that had also received Treg
cells (empty symbols, +Treg) or not (filled sym-
bols, 2Treg). CTLs in single-cell suspensions
of day 7 tumor-draining LNs were analyzed
in the presence (circles) or absence (trian-
gles) of HA-peptide. Dashed line indicates
background staining. Total cellular CD107a
was similar in both populations (Figure S3A).
Insert shows the ratio of specific CD107a
staining of nonregulated versus regulated
CTLs at each time point. Results are pooled
from seven independent experiments with
three mice per group. Mean and standard
deviation are shown.
(B) Degranulation of CTLs with a dominant-
negative TGFbRII from day 7 tumor-draining
LNs of mice transferred with Treg cells (empty
symbols) or not (filled symbols). Results are
pooled from three independent experiments
with three mice per group. Mean and stan-
dard deviation are shown.CTLs exert effector function by secreting cytokines,
such as interferon-g, and by cell contact-dependent
cytotoxic lysis of targets that present a cognate Ag.
The cellular processes governing cytotoxic killing have
been extensively studied (reviewed in Lieberman,
2003), but an experimental approach that allows the
characterization of CTL function on the single-cell level
in vivo has not been described so far. By using MP-
IVM, we now provide a space- and time-resolved analy-
sis of how single CTLs kill their targets in situ. By using
Ag-pulsed B cells as surrogate targets, we show that cy-
totoxic killing is a sequential process consisting of (1)
rapid conjugate formation upon contact; (2) motile but
stable and strictly monogamous interactions with target
B cells, which always lead the way; (3) irreversible motil-
ity arrest of the conjugate; (4) loss of the target’s struc-tural integrity; and finally (5) detachment of the CTLs.
The observation that motility arrest was always followed
by loss of the victim’s structural integrity suggests that
permanent arrest represents the earliest indicator of ir-
reversible cytotoxic damage. The cessation of motility
might reflect a loss of cellular metabolism due to break-
down of mitochondrial function (Martinvalet et al., 2005).
The subsequent loss of structural integrity was probably
triggered by direct and indirect actions of granzymes on
the nuclear envelope, chromatin, and other essential
structural elements (Lieberman, 2003).
Strikingly, similar to what has been described for acti-
vated CD4+ T cells providing help to B cells (Okada et al.,
2005), Ag recognition triggered the immediate forma-
tion of stable contacts between CTLs and Ag-presenting
B cells. By contrast, when naive T cells encounterFigure 6. Treg Cell-Induced CTL Killing Ineffi-
ciency Is Reversible In Vivo upon Removal of
Treg Cells
(A) Content of Thy1.1+ adoptively transferred
Treg cells in LNs of Thy1.2
+ control mice after
injection (bottom) or not (top) of 400 mg
Thy1.1 mAb HIS51 on day 5 and 6 of the im-
mune response. Treg cell depletion was as-
sessed on day 8 by the clonotypic mAb 6.5
and Thy1.1 mAb OX-7.
(B) In vivo killing activity in tumor-draining
LNs was measured on day 8 as described in
Experimental Procedures. Compared to non-
regulated CTLs (2Treg), regulated CTLs
(+Treg) showed reduced cytotoxicity, but
they acquired potent cytotoxic activity after
Treg cell depletion (+Treg, depleted). Mean
and standard deviation from three mice per
group are shown. #p < 0.05 versus +Treg;
*p < 0.05 versus control (tumor-draining LN
without HA-specific CTLs).
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(A) MP-IVM micrographs highlighting the interactive behavior of ds-Red+ Treg cells (red) and EGFP
+ CTLs (green) in tumor-draining LN (day 6).
Upper panels show a brief contact; lower panels show a rare, longer-lasting colocalization. Ag-pulsed B cells and collagen fibers are shown in
blue. Yellow and white dots represent Treg cell and CTL tracks, respectively. These micrographs are from Movie S7. Time passed after capturing
the first image (left) is shown in minutes and seconds. Scale bar equals 20 mm. Similar results were obtained with EGFP+ Treg cells and ds-Red
+
CTLs (not shown).
(B) Duration of contacts of Treg cells with Ag-pulsed B cells, CTLs, and CTL-B cells conjugates (red symbols) and of regulated CTLs with
Ag-pulsed or unpulsed B cells in the same recordings (two independent experiments).Ag-presenting DCs, they undergo a prolonged phase of
transient contacts before engaging in tight interactions
(Hugues et al., 2004; Mempel et al., 2004; Miller et al.,
2004; Tang et al., 2006). This behavioral difference could
be due to the distinct character of the Ag-presenting
cells (mature DC versus B cell) and/or differential re-
sponsiveness to Ag of naive versus primed effector T
cells. In vitro, Ag-presenting B cells support immediate
firm adhesion of T cells, whereas DCs promote only tran-
sient contact (Gunzer et al., 2004). Activated T cells, on
the other hand, are known to respond faster to Ag recog-
nition than naive T cells. The rules that govern this deci-
sion-making process in vivo remain to be defined.
In vitro studies have shown that Treg cells prohibit
activation-induced proliferation of effector T cells (She-
vach, 2002). There is also evidence that suppression of
proliferation is a relevant mechanism of regulation in
certain in vivo settings (Tang et al., 2006). However,
other in vivo studies provide evidence that even under
conditions that allow expansion of effector cells, Treg
cells can attenuate T cell-mediated immune responses,
e.g., in transplantation tolerance (Lin et al., 2002);
chronic viral infection (Dittmer et al., 2004); and in tumor
responses in both mice (Chen et al., 2005a; Thomas and
Massague, 2005) and humans (Curiel et al., 2004; Sato
et al., 2005; Zippelius et al., 2004).
Our MP-IVM recordings show that regulated CTLs oc-
cupy the same LN microenvironment and display similar
motility as unregulated CTLs. Also, regulated CTLs re-
tain the ability to form Ag-dependent motile conjugates,
but they are strikingly inefficient at lysing Ag-presentingtargets. This suggests a disconnection between the sig-
naling events that trigger CTL adhesion to the target cell
and other Ag-triggered cellular functions required for
target cell killing. Indeed, Treg cell-mediated impairment
of CTL function has been suggested previously in a set-
ting of chronic viral infection (Dittmer et al., 2004). More
recently, two studies have reported deficiencies in lytic
effector molecules in CTLs in mouse models of chronic
viral infection (Zelinskyy et al., 2005) and antitumor re-
sponse (Thomas and Massague, 2005). The latter study
also demonstrated that the presence of TGF-b during
in vitro activation of CD8+ T cells leads to diminished
content in perforin, granzymes A and B, Fas ligand,
and IFN-g. In our model, the analysis of mRNA expres-
sion of these effector molecules did not detect compro-
mised differentiation of regulated CTLs. We also did not
find a substantial reduction in granzyme B protein, but
we can not exclude Treg cell-induced changes in content
of other effector molecules due to posttranscriptional
effects, or effects that may be apparent only at different
time points of the immune response. Nevertheless, our
findings indicate that CTL differentiation is minimally
affected by Treg cells. The only striking difference
between regulated and nonregulated CTLs was the
inability of the former to degranulate. Earlier work has
shown that genetic defects in granule secretion (e.g.,
due to Rab27a deficiency) cause a profound inability
of CTLs to kill target cells (Stinchcombe et al., 2001a).
Thus, the Treg cell-induced deficiency in degranulation
is likely to account for the poor cytotoxic activity of reg-
ulated CTLs.
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lease has also been described for NK cells (Bryceson
et al., 2005), which, unlike T cells, express cytolytic
molecules constitutively and are triggered by different
receptors to degranulate (Lieberman, 2003). However,
it remains to be determined whether and to what extent
the control mechanisms of NK degranulation are evoked
in regulated CTLs.
One clue for a potential mechanism by which degran-
ulation may be regulated is suggested by observations in
tumor-infiltrating lymphocytes (TILs) (Koneru et al., 2005;
Radoja et al., 2001). Frey and colleagues found that
freshly isolated TILs that were unable to lyse target cells
contained normal amounts of perforin and granzyme B
but could not polarize their MTOC to release their gran-
ules (Radoja et al., 2001). Upon isolation and culture,
the cells recovered their degranulation capacity and cy-
totoxicity within 12 hr. This recovery depended on pro-
teosomal function and was paralleled by recovery of
MTOC and granule polarization, indicating an active
mechanism of inhibition whose reversal required protein
degradation (Radoja et al., 2001). The degranulation de-
fect in freshly isolated TILs was attributed to dysfunc-
tional proximal TCR signaling (Koneru et al., 2005). In
the present model, the response of regulated LN-resi-
dent CTLs to cognate Ag was indistinguishable from
that of nonregulated CTLs with regard to their prolifera-
tion, activation-induced IFN-g production, and Ag-de-
pendent conjugate formation with target cells. Thus, it
is unlikely that TCR signaling was globally compromised
in the regulated CTLs observed here. However, it is pos-
sible that Treg cell-mediated suppression induces more
subtle changes in signaling cascades triggered by TCR
engagement in CTLs, which might account for the defec-
tive degranulation. Of note, the negative regulator of TCR
signaling, PD-1, has been shown to be expressed on
CTLs in chronic viral infection (Barber et al., 2006). It
will be interesting to determine whether Treg cells
induce PD-1 expression on CTLs, attenuating TCR sig-
naling upon encounter with PD-L1-expressing target
cells. PD-L1 is expressed on several nonhematopoetic
tissues, including a variety of tumors (Latchman et al.,
2004).
Suppression of cytotoxicity was reversible if Treg cells
are depleted after CTL priming, indicating that Treg cells
must continuously ‘‘remind’’ CTLs to maintain suppres-
sion. This rapid (within less than 3 days) reversibility of
suppression could be beneficial in settings where simul-
taneous stimulation of Treg cells and CD8
+ T cells in lym-
phoid organs would allow the generation of large num-
bers of effector cells while preventing the premature
killing of Ag-presenting cells. Once the CTLs have re-
turned to the circulation, they may quickly unleash their
full cytotoxic force upon entering a peripheral site of in-
flammation where Treg cells may either not have access
or their function is antagonized. For example, inflamma-
tory and pathogen-derived signals can release CTLs
from the suppressive effect of Treg cells (Pasare and
Medzhitov, 2003, 2004; Peng et al., 2005; Waldmann
et al., 2004). In this scenario, Treg cell activity in LNs
might paradoxically boost immune responses to patho-
gens by promoting CTL priming in lymphoid tissues and
by focusing their effector activity to peripheral sites of
pathogen invasion.In tissue-culture experiments, cell-cell contact be-
tween Treg cells and regulated T cells seems to be re-
quired for suppression, while cytokines are dispensable
(Shevach, 2002). However, in vivo studies imply an
important role for secreted mediators, especially
TGF-b (Gorelik and Flavell, 2002). Since we could re-
verse suppression of CTLs by depletion of Treg cells after
day 5 of the immune response, we conclude that regula-
tion is still ongoing and required at this late time point.
However, while CTLs formed numerous long-lasting
motile conjugates with peptide-pulsed B cells, the mi-
grating Treg cells in the same field of view collided only
briefly with B cells, CTLs, or B cell-CTL conjugates;
long-lived ternary aggregates between B cells, CTLs,
and Treg cells were absent. Nevertheless, B cells were
rarely killed in this setting, indicating that CTL suppres-
sion does not require prolonged Treg cell contact with
either the effector cells or their targets. It is possible
that contact-dependent suppressive signals (e.g.,
through the CD28-CTLA-4 pathway [Sakaguchi, 2004])
are exchanged during the brief collisions between acti-
vated Treg cells and CTLs. However, our results suggest
that Treg cells exert their activity on CTLs, at least in part,
by inducing a local milieu that is rich in TGF-b and prob-
ably other suppressive factors. Such a regulatory envi-
ronment prohibits CTL degranulation and, thus, cytoly-
sis, independent of effects during T cell priming.
A recent multiphoton microscopy study on Treg cell
function in excised pancreatic LNs of diabetes-prone
mice reported that Treg cells undergo tight interactions
only with islet-Ag presenting DCs, but not with diabeto-
genic CD4+ effector cells (Tang et al., 2006). This is con-
sistent with the present finding that Treg cells in tumor-
draining LNs do not engage in stable contacts with
CTLs, although DCs (or other tumor Ag-presenting cells)
were not visualized here. In the autoimmune diabetes
model, the presence of Treg cells impaired proliferation
and expansion of diabetogenic CD4+ T cells, while CTL
proliferation was not affected in our tumor model. How-
ever, inhibition of proliferation of diabetogenic T cells
was observed only when islet Ag-specific Treg cells
were transferred 2 days earlier, thus allowing the Treg
cells sufficient time to become activated and, presum-
ably, to alter DC function (Tang et al., 2006). Simulta-
neous transfer of Treg cells and effector cell precursors
(similar to the protocol used here) did not block effector
cell proliferation (Tang et al., 2006), even though the de-
layed transfer of Treg cells is still sufficient to prohibit dis-
ease in diabetes-prone mice (Tang et al., 2004). Indeed,
another study found that the control of diabetogenic ef-
fector cells by naturally occurring endogenous Treg cells
does not affect the expansion or differentiation of effec-
tor cells in pancreatic LNs (Chen et al., 2005b). In this
setting, effector cell precursors and Treg cells are likely
to encounter islet Ags at the same time (Turley et al.,
2003). Although these studies investigated the suppres-
sion of autoreactive CD4+ T cells, a striking commonality
with our observations of foreign Ag-specific CTLs is that
simultaneous activation of Treg cells leads to effector
suppression without impairment of effector expansion
at the priming site.
These diverse observations emphasize that Treg cells
can suppress immune responses at multiple levels and
that distinct or even contradictory mechanisms and
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out under different circumstances. In our model, the ini-
tially small number of LN-resident Treg cells probably
first need to be activated and clonally expand before
they can confer suppressive signals to CTLs. Thus, reg-
ulation may only take effect late after CTL priming and
effector differentiation.
In conclusion, our results show that Treg cells can se-
lectively interfere with the release of cytolytic granules
by CTLs in a reversible and TGF-b-dependent manner.
Thereby, Treg cells attenuate CTL cytotoxicity without
detectably affecting priming or differentiation. This find-
ing has implications for the design of therapeutic strate-
gies that rely on modulating ongoing immune re-
sponses. Our findings support the notion that local or
systemic interference with suppressor pathways of
CTL activity, e.g., with cytokines (Sakaguchi et al.,
1995; Shevach, 2002) or Toll-like receptor agonists (Pa-
sare and Medzhitov, 2003, 2004; Peng et al., 2005) or Treg
cell depletion (Yang et al., 2004), may be effective in the
case of tumor therapy, where immunity is desired. Con-
versely, promoting suppression by targeting pathways
that enhance or mimic Treg cell activity may be clinically




DPE-GFP and T-Red transgenic mice were generated by means of
modifications of a previously described construct (Manjunath
et al., 1999), which induce uniform and selective expression of
EGFP or ds-RedII, respectively, in T cells, including effector cells.
DPE-GFP 3 TCR-CL4 3 Rag-2–/– mice were generated by crossing
the DPE-GFP strain to TCR-CL4 3 Rag-2–/– mice, which express
a transgenic TCR specific for H-2Kd/HA512-520 (Morgan et al.,
1996). T-Red 3 pgk-HA 3 TCR-HA mice were obtained by crossing
T-Red mice to pgk-HA3 TCR-HA mice expressing influenza-HA un-
der the control of the phosphoglyerate kinase promotor and a trans-
genic TCR specific for I-Ed/HA107-119 (Chen et al., 2005a). T-Red 3
TCR-CL4 3 Rag-22/2 and DPE-GFP 3 pgk-HA 3 TCR-HA mice
were generated accordingly. TCR-CL4 3 Rag-2–/– mice were also
crossed to dnTGFbRII transgenic mice, a generous gift from
Dr. Richard Flavell (Gorelik and Flavell, 2000). Thy1.1+ BALB/c
mice were obtained from Dr. Paul Allen and used as such or crossed
to the pgk-HA3 TCR-HA mice. Thy1.2+ BALB/c mice were obtained
from Jackson Laboratories. All mice were housed in specific patho-
gen-free conditions in compliance with guidelines set by the Sub-
Committee on Animal Research Care at the Massachusetts General
Hospital.
Cells
HA-specific CD8+ T cells and HA-specific CD4+ CD25+ regulatory T
cells were purified from DPE-GFP TCR-CL4 3 Rag-2–/– or TCR-
CL4 3 Rag-2–/– mice and T-Red 3 pgk-HA 3 TCR-HA or pgk-HA 3
TCR-HA mice, respectively, as described (Chen et al., 2005a). B cells
from LNs and spleens of Thy1.1+ mice were purified by CD43-
negative immunomagnetic cell sorting (Miltenyi Biotec). Purity was
typically greater than 95%. The tumor cell line CT44 was generated
by stably transfecting CT26 cells (ATCC, Manassas, VA) with a fusion
protein of influenza haemagglutinin and EGFP (Klein et al., 2003b).
mAbs and Flow Cytometry
TCR-HA mAb (clone 6.5) was grown and purified according to stan-
dard procedures. All other mAbs were from BD Pharmingen. Pheno-
typic characterization of T and B cells was performed on a FACSCa-
libur (Becton Dickinson).Ex Vivo Degranulation Assay
CTL granule exocytosis was measured as mobilization of the lyso-
somal marker CD107a (Lamp-1) to the cell surface as described
(Betts et al., 2003). In brief, tumor-draining LNs containing locally
primed HA-specific CTLs and either HA-specific Treg cells or not
were harvested on day 6 or 7. HA512-520, HA107-119, and FITC-conju-
gated CD107a mAb were then added to LN cell suspensions on ice
and aliquots taken at various time points after rapidly warming to
37C to trigger Ag-induced degranulation and detect CD107a mole-
cules subsequently exposed at the cell surface. After all aliquots had
been sampled, cell suspensions were stained for 20 min on ice for
the congenic marker Thy1.2 and for CD8a to identify HA-specific
CTLs as well as for CD107a to adjust unspecific background staining
between all samples and analyzed by flow cytometry.
In Vitro Imaging of CTLs
To assess secretory granule content, CTLs were sorted from LNs
and stained with 50 nM Lysotracker Red (Molecular Probes) (Lyub-
chenko et al., 2001; Stinchcombe et al., 2001b) for 2 hr and either
analyzed by flow cytometry or additionally stained with 2.5 mM
Hoechst33342 and 5 mM carboxyfluoresceine diacetate, succini-
midyl ester (CFSE, Molecular Probes), and adhered to poly-l-
lysine-coated cover slips and imaged by confocal microscopy.
Real-Time RT-PCR
Aliquots of 103 CTLs were sorted from LNs on day 6, and mRNA
levels for various genes were determined as described (Peixoto
et al., 2004). Expression levels were normalized for CD33 mRNA,
since CD33 protein was expressed on the cell surface at similar
levels and CD33 message levels did not vary between regulated
and unregulated CTLs in the same experiment.
In Vivo Treg Cell Depletion
Thy1.2+ BALB/c mice received intravenous injections of 105 HA-spe-
cific Thy1.2+ CD8+ T cells and 105 HA-specific Thy1.1+ CD4+ CD25+
Treg cells, followed by implantation of HA-expressing tumors into the
footpad. Thy1.1+ Treg cells were depleted from Thy1.2
+ mice con-
taining Thy1.2+ CTLs by intravenous injections of anti-Thy1.1 mAb
(HIS51, 400 mg/day) on day 5 and 6 of the immune response.
In Vivo Killing Assay
HA512-520-pulsed and unpulsed B cells were incubated with 0.2 mM
(CFSElow) and 2 mM CFSE (CFSEhigh) for 15 min in PBS-1% FBS, re-
spectively, and 23 107 total cells injected intravenously at a 1:1 ratio
into tumor-bearing recipients that had either not received T cells or
received HA-specific CD8+ T cells together with or without Treg cells
(‘‘exp’’). After 6 hr, the frequency of pulsed and unpulsed B cells
was determined in tumor-draining LNs by FACS. Injection of mice
that had received neither tumors nor T cells served to control for
variability in B cell input ratio and unspecific B cell death (‘‘ctrl’’). Per-
cent specific lysis was calculated as follows: (1 2 CFSElow(exp)/
CFSEhigh(exp) / CFSElow(ctrl)/CFSEhigh(ctrl)) 3 100 (%).
Intravital Multiphoton Microscopy
B cells were pulsed with HA512-520 (Biosource) or left unpulsed, la-
beled for 30 min at 37C with 2.5 mM Hoechst33342 (Molecular
Probes), and then washed and labeled for 15 min at 37C with
20 mM 5-(and 6-)-(((4-chloromethyl) benzoyl) amino) tetramethylr-
hodamine (CMTMR; Molecular Probes). 2 3 107 B cells in 100 ml
RPMI were injected i.v. into tumor-bearing mice. At various time
points during the following 15 hr, mice were anesthetized and the tu-
mor-draining popLN was prepared microsurgically for MP-IVM on
a BioRad 2100MP system as described (Mempel et al., 2004). For
multiphoton excitation and second harmonic generation, a MaiTai
Ti:sapphire laser (Spectra-Physics) was tuned between 900 and
960 nm to balance excitation of the various fluorescent probes
used. For four-dimensional analysis of cell migration, stacks of 11
square x-y sections with 4 mm z spacing were acquired every 15 s
with electronic zooming up to 43 to provide image volumes 40 mm
in depth and between 154 and 618 mm in width. Emitted light and
second harmonic signals were detected through 450/80 nm,
525/50 nm, and 630/120 nm band-pass filters with nondescanned
detectors to generate three-color images. Sequences of image
stacks were transformed into volume-rendered, four-dimensional
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140time-lapse movies with Volocity software (Improvision). Velocity
measurements were done by semiautomated cell tracking with
Volocity (Improvision) and computational analysis by Matlab (Math-
works). Red and blue mean fluorescence pixel intensities of B cells
rendered in maximum intensity projections were measured on single
cells with Openlab (Improvision).
Parameters of cell motility were determined as described previ-
ously (Sumen et al., 2004). To display the 3D velocity of individual
migrating B cells, velocity tracks were smoothed by calculating
the time-averaged instantaneous velocity, which represents the
mean of 21 individual instantaneous velocity measurements derived
for each time point from the 10 preceding and the 10 subsequent
determinations. This parameter was also used to discern motile
from immotile cells via a reference population of 40 viable B cells,
95% of which had a mean track velocity >3.9 mm/min. B cells whose
time-averaged velocity was permanently below this 5th percentile
cutoff were defined as immotile. The fact that the measured velocity
of most immotile cells was >0 mm/min is due to movement or drift of
the preparation and passive displacement of dead cells colliding
with migrating viable cells.
In each individual MP-IVM recording (n = 22 recordings in 9 mice),
laser power, excitiation wavelength, and gain settings were adjusted
for optimally balanced signal intensities in all color channels at
a given imaging depth. Due to case-by-case differences in these ac-
quisition parameters, the mean R/B ratios of viable motile B cells that
did not interact with CTL were somewhat variable, ranging from 0.87
to 2.93 (mean6SD: 1.436 0.42). To allow a side-by-side comparison
of R/B ratios from different recordings, we calculated the average R/
B ratio of viable cells from all 22 recordings, R=Bglobal . We then deter-
mined the correction factor c for each individual recording according
to c= R=Bglobal / R=Bexp, where R=Bexp is the mean R/B ratio of all mo-
tile noninteracting B cells within that recording. This correction factor
was then applied to the measured R/B ratio of each individual B cell
(motile or immotile), R/Bcell, in the same recording to obtain the cor-
rected R/B ratio: R/Bcorrected = R/Bcell 3 c. All results referred to as
‘‘R/B ratio’’ in figures and text represent R/Bcorrected. Individual B
cells were considered to be structurally damaged when their
R/Bcorrected dropped below 0.95, which represents the 5
th percentile
ofR/Bcorrectedvalues from a reference population consisting of all 470
viable B cells analyzed in this study.
Statistical Analysis
Unless indicated otherwise, data are expressed as mean 6 SEM.
Differences between groups were tested via an unpaired, two-tailed
t test.
Supplemental Data
Supplemental Data include six figures and seven movies and can be
found with this article online at http://www.immunity.com/cgi/
content/full/25/1/129/DC1/.
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